BridgeMD
Fast awakening from general anesthesia, an observational intervention study in healthy volunteers
EU CTIS ID: 2024-516415-24-03
What this study is testing
To investigate the duration and efficiency of rapid sequence emergence of general anaesthesia
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Age 18-65
- ASA ≤ II (no systemic diseases, including cardiac, pulmonary, liver and kidney diseas-es or epilepsy)
You likely can't join if
- No informed consent
- Allergic reaction for one of the used agents
- Expected or known difficult airway
- BMI > 30
- Pregnancy (anamnestic or use of oral anticonceptives). One of the medicines we use (sugammadex) can temporarily increase the risk of pregnancy. This is equivalent to one missed pill
- ASA > II
See the full eligibility criteria
- Age 18-65
- ASA ≤ II (no systemic diseases, including cardiac, pulmonary, liver and kidney diseas-es or epilepsy)
- No informed consent
- Allergic reaction for one of the used agents
- Expected or known difficult airway
- BMI > 30
- Pregnancy (anamnestic or use of oral anticonceptives). One of the medicines we use (sugammadex) can temporarily increase the risk of pregnancy. This is equivalent to one missed pill
- ASA > II
- Systemic diseases or epilepsy
- Use of alcohol < 24 hr and drugs < 48 hr before start of the trial
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.